http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-970027080-A
Outgoing Links
| Predicate | Object |
|---|---|
| filingDate | 1996-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1997-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-970027080-A |
| titleOfInvention | Alkyl xanthine phosphonates and alkyl xanthine phosphine oxides and their use as medicaments |
| abstract | The compound of formula (1) has been shown to be a result of infection, acquired immunodeficiency, cancer, trauma and other diseases with increased protein loss, muscle atrophy, cachexia, muscular dystrophy, sepsis, septic shock, toxic shock, systemic inflammatory response Syndrome, adult respiratory distress syndrome, cerebral malaria, chronic pneumonia, pulmonary sarcoidosis, reperfusion injury, scar formation, intestinal inflammation and ulcerative colitis, peripheral circulatory system disease, changes in leukocyte adhesion, and rheumatoid arthritis, rheumatoid spondylitis, osteoarthritis And other medicaments for the treatment of other diseases involving increased or unregulated tumor necrosis factor production, such as other arthritis diseases.n n n n n n n n In the formula (1), R 1 and R 3 are the same or different and at least one of the radicals R 1 and R 3 is a radical of the formula (2).n n n n n n n n Wherein E is a covalent bond or (C 1 -C 5 ) alkyl. |
| priorityDate | 1995-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.